Effects on the QT Interval of a Gatifloxacin-Containing Regimen versus Standard Treatment of Pulmonary Tuberculosis

Effects on the QT Interval of a Gatifloxacin-Containing Regimen versus Standard Treatment of Pulmonary Tuberculosis

The effects on ventricular repolarization-recorded on the electrocardiogram (ECG) as lengthening of the QT interval-of acute tuberculosis and those of standard and alternative antituberculosis regimens are underdocumented. A correction factor (QTc) is introduced to make the QT independent of the hea...

Full description

Bibliographic Details
Main Authors:	Olliaro, P, Merle, C, Mthiyane, T, Bah, B, Kassa, F, Amukoye, E, N Diaye, A, Perronne, C, Lienhardt, C, McIlleron, H, Fielding, K
Format:	Journal article
Language:	English
Published:	American Society for Microbiology 2017

Similar Items

A pivotal registration phase III, multicenter, randomized tuberculosis controlled trial: design issues and lessons learnt from the Gatifloxacin for TB (OFLOTUB) project
by: Merle Corinne SC, et al.
Published: (2012-05-01)

Gatifloxacin Pharmacokinetics/Pharmacodynamics-based Optimal Dosing for Pulmonary and Meningeal Multidrug-resistant Tuberculosis
by: Deshpande, D, et al.
Published: (2018)

Scoping review: QT interval prolongation in regimen containing bedaquiline and delamanid in patients with drug-resistant tuberculosis
by: Oki Nugraha Putra, et al.
Published: (2022-01-01)

Getting drug doses right in children with tuberculosis (TB)
by: H. McIlleron
Published: (2014-04-01)

Randomized clinical trial of thrice-weekly 4-month moxifloxacin or gatifloxacin containing regimens in the treatment of new sputum positive pulmonary tuberculosis patients.
by: Mohideen S Jawahar, et al.
Published: (2013-01-01)

PROLONGATION OF QT INTERVAL DURING CHEMOTHERAPY OF PULMONARY TUBERCULOSIS
by: K. I. Martynyuk, et al.
Published: (2018-07-01)

Surface-modified gatifloxacin nanoparticles with potential for treating central nervous system tuberculosis
by: Marcianes P, et al.
Published: (2017-03-01)

Principles for designing future regimens for multidrug-resistant tuberculosis
by: Grania Brigden, et al.
Published: (2014-01-01)

A model-based approach for a practical dosing strategy for the short, intensive treatment regimen for paediatric tuberculous meningitis
by: Roeland E. Wasmann, et al.
Published: (2023-04-01)

BROMATOMATRIC ASSAY OF GATIFLOXACIN IN PHARMACEUTICALS
by: KALSANG THARPA, et al.
Published: (2008-09-01)

Effect of QT interval-prolonging drugs taken in pregnancy on the neonatal QT interval
by: Holger Michel, et al.
Published: (2023-08-01)

QT interval prolongation and with donepezil, rivastigmine and galantamine
by: Katie Malone, et al.
Published: (2020-08-01)

Moxifloxacin and gatifloxacin for initial therapy of tuberculosis: a meta-analysis of randomized clinical trials
by: Qiaoling Ruan, et al.
Published: (2016-01-01)

Short QT interval syndrome
by: I. G. Fomina, et al.
Published: (1970-01-01)

An analysis of the electrocardiogram QT interval
by: N.R. Koehler, et al.
Published: (2004-01-01)

Corrected QT interval and QT dispersion in temporal lobe epilepsy
by: Maram Samy Nasef, et al.
Published: (2021-01-01)

The effect of the current chemotherapy of MDR/XDR tuberculosis on QT interval changes in ECG
by: E. M. Zhukova, et al.
Published: (2019-12-01)

Corrected QT interval and corrected QT interval dispersion is worthwhile when interpreted with other repolarization measurements
by: Mehmet Dogan, et al.

Characterizing the gene mutations associated with resistance to gatifloxacin in Mycobacterium tuberculosis through whole-genome sequencing
by: Jing Bi, et al.
Published: (2021-11-01)

Bedaquiline Effect on QT Interval of Drugs-Resistant Tuberculosis Patients: Real World Data
by: I Gusti Agung Ayu Putu Sri Darmayani, et al.
Published: (2022-07-01)

Acquired long QT interval in athletes
by: A. S. Yunisova, et al.
Published: (2022-05-01)

Drugs that enlarge the QT interval of the electrocardiogram.
by: Pedro Miguel Milián Vázquez., et al.
Published: (2006-12-01)

Drugs that enlarge the QT interval of the electrocardiogram.
by: Pedro Miguel Milián Vázquez., et al.
Published: (2006-12-01)

QT Interval Prolongation in Cirrhotic Cardiomyopathy
by: Tadelle A
Published: (2022-07-01)

No Widening of QT Interval during Bradycardia
by: Bonpei Takase, MD
Published: (2011-01-01)

Repolarization Heterogeneity: Beyond the QT Interval
by: Stuart B. Prenner, et al.
Published: (2016-05-01)

Assessment of corrected QT interval and QT dispersion in patients with uncomplicated metabolic syndrome
by: Amandeep Kaur, et al.
Published: (2023-01-01)

The QT Intervals in Infancy and Time for Infantile ECG Screening for Long QT Syndrome
by: Masao Yoshinaga, MD PhD, et al.
Published: (2011-01-01)

QT PRODACT: In Vivo QT Assay in the Conscious Dog for Assessing the Potential for QT Interval Prolongation by Human Pharmaceuticals
by: Shigeki Toyoshima, et al.
Published: (2005-01-01)

Increases of QT dispersion, corrected QT dispersion and QT interval in young healthy individuals during Ramadan fasting
by: Moradmand S, et al.
Published: (2003-06-01)

QT PRODACT: In Vivo QT Assay in Anesthetized Dog for Detecting the Potential for QT Interval Prolongation by Human Pharmaceuticals
by: Hiroyuki Tashibu, et al.
Published: (2005-01-01)

Increases of QT dispersion, corrected QT dispersion and QT interval in young healthy individuals during Ramadan fasting
by: Moradmand S, et al.
Published: (2003-06-01)

Pharmacokinetics of antiretroviral drugs in infancy
by: Helen McIlleron, et al.
Published: (2009-12-01)

QT Interval Prolongation in Patients with Systemic Sclerosis—Are the Holter ECG Recordings a Better Option for QT Interval Evaluation?
by: Elena E. Saramet, et al.
Published: (2021-03-01)

Relationship between QT interval and ventricular electrical axis: A new suggestion for Lead selection in QT interval measurement
by: "Moradman S, et al.
Published: (2000-09-01)

Relationship between QT interval and ventricular electrical axis: A new suggestion for Lead selection in QT interval measurement
by: "Moradman S, et al.
Published: (2000-10-01)

QT PRODACT: In Vivo QT Assay With a Conscious Monkey for Assessment of the Potential for Drug-Induced QT Interval Prolongation
by: Kentaro Ando, et al.
Published: (2005-01-01)

The dark side of the QT interval. The Short QT Syndrome: pathophysiology, clinical presentation and management
by: I. Comelli, et al.
Published: (2012-12-01)

Automated QT interval analysis with confidence measures
by: Hughes, N, et al.
Published: (2004)

Smart devices to measure and monitor QT intervals
by: Leendert J. Hoek, et al.
Published: (2023-11-01)